Differences in BCG vaccination and tuberculin skin-test positivity
Lancet Infect Dis
.
2015 Sep;15(9):1003.
doi: 10.1016/S1473-3099(15)00233-9.
Authors
Anissa Sidibe
1
,
Alberto Matteelli
2
,
Richard Menzies
2
,
Haileyesus Getahun
2
Affiliations
1
Global Tuberculosis Programme, World Health Organization, Geneva 1211, Switzerland. Electronic address:
[email protected]
.
2
Global Tuberculosis Programme, World Health Organization, Geneva 1211, Switzerland.
PMID:
26333326
PMCID:
PMC5642862
DOI:
10.1016/S1473-3099(15)00233-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Humans
Latent Tuberculosis / epidemiology*
Male
Grants and funding
001/WHO_/World Health Organization/International